FDA Safety Communication: Stop Using Empowered Diagnostics COVID-19 Test
- Access Compliance

- Feb 1, 2022
- 1 min read

Please see the January 28th, US Food & Drug Administration safety communication.
The FDA has identified this issue as a Class I recall, the most serious type of recall.









Comments